NCT03968822View on ClinicalTrials.gov

Intralipid® 20% for Reversal of Local Anesthetics

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 26, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Anesthesia, Local
Interventions
DRUG

Lidocaine 2%

3 mL of test solution to a skin area on the thigh, 2cm in diameter

DRUG

Lidocaine 1%

3 mL of test solution to a skin area on the thigh, 2cm in diameter

DRUG

Bupivacaine 0.25%

3 mL of test solution to a skin area on the thigh, 2cm in diameter

DRUG

Bupivacaine 0.5%

3 mL of test solution to a skin area on the thigh, 2cm in diameter

DRUG

Intralipid, 20% Intravenous

a 250ml bag administered intravenously

OTHER

Saline intravenously

a 250ml bag administered intravenously

OTHER

Saline

3 mL of test solution to a skin area on the thigh, 2cm in diameter

Trial Locations (1)

10021

Hospital of Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER